Regulation of human methylthioadenosine phosphorylase gene by the CBF (CCAAT binding factor)/NF-Y (nuclear factor-Y)

Biochemical Journal

Volumn 387, Issue 1, 2005, Pages 175-183

  Kadariya, Yuwaraj ^a,b   Nakatani, Kaname ^a   Nishioka, Junji ^a   Fujikawa, Takahiko ^a   Kruger, Warren D ^b   Nobori, Tsutomu ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

5 deoxy 5 methylthioadenosine phosphorylase (MTAP); CCAAT motif; Chromatin immunoprecipitation; Luciferase; Nuclear factor Y (NF Y); Promoter

Indexed keywords

AMINO ACIDS; BIOASSAY; COMPLEXATION; ELECTROPHORESIS; ENZYMES; PRECIPITATION (CHEMICAL); TUMORS;

ELECTROPHORETIC MOBILITY; HUMAN TUMOR CELLS; METHIONINE; TRANSCRIPTIONAL REGULATION;

GENES;

5' METHYLTHIOADENOSINE PHOSPHORYLASE; CCAAT BINDING FACTOR; CIS ACTING ELEMENT; METHIONINE; NUCLEAR FACTOR; NUCLEAR FACTOR Y; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ARTICLE; BINDING ASSAY; CHROMATIN; CONTROLLED STUDY; ENZYME INACTIVATION; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE MAPPING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR CLONING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN RNA BINDING; REGULATORY MECHANISM; REGULATORY SEQUENCE; REPORTER GENE; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; TUMOR CELL;

BASE SEQUENCE; CCAAT-BINDING FACTOR; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MOLECULAR SEQUENCE DATA; PLACENTA; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PURINE-NUCLEOSIDE PHOSPHORYLASE; RESPONSE ELEMENTS; TRANSCRIPTION INITIATION SITE;

EID: 17144384370     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20041472     Document Type: Article

References (52)

1. Chen, Z. H., Zhang, H. and Savarese, T. M. (1996) Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy. Cancer Res. 56, 1083-1090
2. Hori, H., Tran, P., Carrera, C. J., Hori, Y., Rosenbach, M. D., Carson, D. A. and Nobori, T. (1996) Methylthioadenosine phosphorylase cDNA transfection alters sensitivity to depletion of purine and methionine in A549 lung cancer cells. Cancer Res. 56, 5653-5658
3. Kamatani, N., Nelson-Rees, W. A. and Carson, D. A. (1981) Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme. Proc. Natl. Acad. Sci. U.S.A. 78, 1219-1223
4. Myers, R. W. and Abeles, R. H. (1990) Conversion of 5-S-methyl-5-thio-D- ribose to methionine in Klebsiella pneumoniae. Stable isotope incorporation studies of the terminal enzymatic reactions in the pathway. J. Biol. Chem. 265, 16913-16921
5. Backlund, Jr, P. S., Chang, C. P. and Smith, R. A. (1982) Identification of 2-keto-4-methylthiobutyrate as an intermediate compound in methionine synthesis from 5′-methylthioadenosine. J. Biol. Chem. 257, 4196-4202
6. Backlund, Jr, P. S. and Smith, R. A. (1982) 5′-Methylthioadenosine metabolism and methionine synthesis in mammalian cells grown in culture. Biochem. Biophys. Res. Commun. 108, 687-695
7. Marchitto, K. S. and Ferro, A. J. (1985) The metabolism of 5′-methylthioadenosine and 5-methylthioribose 1-phosphate in Saccharomyces cerevisiae. J. Gen. Microbiol. 131, 2153-2164
8. Cone, M. C., Marchitto, K., Zehfus, B. and Ferro, A. J. (1982) Utilization by Saccharomyces cerevisiae of 5′-methylthioadenosine as a source of both purine and methionine. J. Bacteriol. 151, 510-515
9. Olopade, O. I., Pomykala, H. M., Hagos, F., Sveen, L. W., Espinosa, III, R., Dreyling, M. H., Gursky, S., Stadler, W. M., Le Beau, M. M. and Bohlander, S. K. (1995) Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21. Proc. Natl. Acad. Sci. U.S.A. 92, 6489-6493
10. Yu, J., Batova, A., Shao, L., Carrera, C. J. and Yu, A. L. (1997) Presence of methylthioadenosine phosphorylase (MTAP) in hematopoietic stem/progenitor cells: its therapeutic implication for MTAP (-) malignancies. Clin. Cancer Res. 3, 433-438
11. Toohey, J. I. (1978) Methylthioadenosine nucleoside phosphorylase deficiency in methylthio-dependent cancer cells. Biochem. Biophys. Res. Commun. 83, 27-35
12. Schmid, M., Malicki, D., Nobori, T., Rosenbach, M. D., Campbell, K., Carson, D. A. and Carrera, C. J. (1998) Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC). Oncogene 17, 2669-2675
13. Merlo, A., Gabrielson, E., Mabry, M., Vollmer, R., Baylin, S. B. and Sidransky, D. (1994) Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Cancer Res. 54, 2322-2326
14. Stadler, W. M. and Olopade, O. I. (1996) The 9p21 region in bladder cancer cell lines: large homozygous deletion inactivate the CDKN2, CDKN2B and MTAP genes. Urol. Res. 24, 239-244
15. Van der Riet, P., Nawroz, H., Hruban, R. H., Corio, R., Tokino, K., Koch, W. and Sidransky, D. (1994) Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res. 54, 1156-1158
16. Wong, Y. F., Chung, T. K., Cheung, T. H., Nobori, T. and Chang, A. M. (1998) MTAP gene deletion in endometrial cancer. Gynecol. Obstet. Invest. 45, 272-276
17. Christopher, S. A., Diegelman, P., Porter, C. W. and Kruger, W. D. (2002) Methylthioadenosine phosphorylase, a gene frequently codeleted with p16 (cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line. Cancer Res. 62, 6639-6644
18. Bello, M. J. and Rey, J. A. (1990) Chromosome aberrations in metastatic ovarian cancer: relationship with abnormalities in primary tumors. Int. J. Cancer 45, 50-54
19. Barker, F. G., Chen, P., Furman, F, Aldape, K. D., Edwards, M. S. and Israel, M. A. (1997) P16 deletion and mutation analysis in human brain tumors. J. Neurooncol. 31, 17-23
20. Jagasia, A. A., Block, J. A., Qureshi, A., Diaz, M. O., Nobori, T., Gitelis, S. and Iyer, A. P. (1996) Chromosome 9 related aberrations and deletions of the CDKN2 and MTS2 putative tumor suppressor genes in human chondrosarcomas. Cancer Lett. 105, 91-103
21. Garcia-Castellano, J. M., Villanueva, A., Healey, J. H., Sowers, R., Cordon-Cardo, C., Huvos, A., Bertino, J. R., Meyers, P. and Gorlick, R. (2002) Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma. Clin. Cancer Res. 8, 782-787
22. Subhi, A. L., Diegelman, P., Porter, C. W., Tang, B., Lu, Z. J., Markham, G. D. and Kruger, W. D. (2003) Methylthioadenosine phosphorylase regulates ornithine decarboxylase by production of downstream metabolites. J. Biol. Chem. 278, 49868-49873
23. Mori, T., Miura, K., Aoki, T., Nishihira, T., Mori, S. and Nakamura, Y. (1994) Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res. 54, 3396-3397
24. Jen, J., Harper, J. W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S., Willson, J. K., Kinzler, K. W. and Vogelstein, B. (1994) Deletion of p16 and p15 genes in brain tumors. Cancer Res. 54, 6353-6358
25. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K. and Carson, D. A. (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (London) 368, 753-756
26. Hori, Y., Hori, H., Yamada, Y., Carrera, C. J., Tomonaga, M., Kamihira, S., Carson, D. A. and Nobori, T. (1998) The methylthioadenosine phosphorylase gene is frequently co-deleted with the p16INK4a gene in acute type adult T-cell leukemia. Int. J. Cancer 75, 51-56
27. Batova, A., Diccianni, M. B., Omura-Minamisawa, M., Yu, J., Carrera, C. J., Bridgeman, L. J., Kung, F. H., Pullen, J., Amylon, M. D. and Yu, A. L. (1999) Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro. Cancer Res. 59, 1492-1497
28. Dreyling, M. H., Roulston, D., Bohlander, S. K., Vardiman, J. and Olopade, O. I. (1998) Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma. Genes Chromosomes Cancer 22, 72-78
29. Illei, P. B., Rusch, V. W., Zakowski, M. F. and Ladanyi, M. (2003) Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. Clin. Cancer Res. 9, 2108-2113
30. Cowan, J. M., Halaban, R. and Francke, U. (1988) Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. J. Natl. Cancer. Inst. 80, 1159-1164
31. Behrmann, I., Wallner, S., Komyod, W., Heinrich, P. C., Schuierer, M., Buettner, R. and Bosserhoff, A. K. (2003) Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma. Am. J. Pathol. 163, 683-690
32. Kadariya, Y., Nishioka, J., Nakatani, K., Nakashima, K. and Nobori, T. (2002) Deletion of dinucleotide repeat (delta14 allele) in the methylthioadenosine phosphorylase (MTAP) promoter and the allelotype of MTAP promoter in the Japanese population. Jpn. J. Cancer Res. 93, 369-373
33. Nobori, T., Takabayashi, K., Tran, P., Orvis, L., Batova, A., Yu, A. L. and Carson, D. A. (1996) Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers. Proc. Natl. Acad. Sci. U.S.A. 93, 6203-6208
34. Sanger, F., Coulson, A. R., Barrell, B. G., Smith, A. J. and Roe, B. A. (1980) Cloning in single-stranded bacieriophage as an aid to rapid DNA sequencing. J. Mol. Biol. 143, 161-178
35. De Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R. and Subramani, S. (1987) Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7, 725-737
36. Henikoff, S. (1984) Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. Gene 28, 351-359
37. Hoheisel, J. and Pohl, F. M. (1986) Simplified preparation of unidirectional deletion clones. Nucleic Acids Res. 14, 3605-3616
38. Martelin, E., Palvimo, J. J., Lapatto, R. and Raivio, K. O. (2000) Nuclear factor Y activates the human xanthine oxidoreductase gene promoter. FEBS Lett. 480, 84-88
39. Dignam, J. D., Lebovitz, R. M. and Roeder, R. G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489
40. Mantovani, R. (1998) A survey of 178 NF-Y binding CCAAT boxes. Nucleic Acids Res. 26, 1135-1143
41. Benoist, C., O'Hare, K., Breathnach, R. and Chambon, P. (1980) The ovalbumin gene-sequence of putative control regions. Nucleic Acids Res. 8, 127-142
42. Efstratiadis, A., Posakony, J. W., Maniatis, T., Lawn, R. M., O'Connell, C., Spritz, R. A., DeRiel, J. K., Forget, B. G., Weissman, S. M., Slightom, J. L. et al. (1980) The structure and evolution of the human beta-globin gene family. Cell (Cambridge, Mass.) 21, 653-668
43. McKnight, S. and Tjian, R. (1986) Transcriptional selectivity of viral genes in mammalian cells. Cell (Cambridge, Mass.) 46, 795-805
44. Mantovani, R. (1999) The molecular biology of the CCAAT-binding factor NF-Y. Gene 239, 15-27
45. Maity, S. N., Golumbek, P. T., Karsenty, G. and de Crombrugghe, B. (1988) Selective activation of transcription by a novel CCAAT binding factor. Science 241, 582-585
46. Hasegawa, T., Zhou, X., Garrett, L. A., Ruteshouser, E. C., Maity, S. N. and de Crombrugghe, B. (1996) Evidence for three major transcription activation elements in the proximal mouse proalpha2(I) collagen promoter. Nucleic Acids Res. 24, 3253-3260
47. Bi, W., Wu, L., Coustry, F., de Crombrugghe, B. and Maity, S. N. (1997) DNA binding specificity of the CCAAT-binding factor CBF/NF-Y. J. Biol. Chem. 272, 26562-26572
48. Chodosh, L. A., Baldwin, A. S., Carthew, R. W. and Sharp, P. A. (1988) Human CCAAT-binding proteins have heterologous subunits. Cell (Cambridge, Mass.) 53, 11-24
49. Faniello, M. C., Bevilacqua, M. A., Condorelli, G., de Crombrugghe, B., Maity, S. N., Avvedimento, V. E., Cimino, F. and Costanzo, F. (1999) The B subunit of the CCAAT-binding factor NF-Y binds the central segment of the co-activator p300. J. Biol Chem. 274, 7623-7626
50. Wade, P. A., Pruss, D. and Wolffe, A. P. (1997) Histone acetylation: chromatin in action. Trends Biochem. Sci. 22, 128-132
51. Kadonaga, J. T. (1998) Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines. Cell (Cambridge, Mass.) 92, 307-313
52. Grunstein, M. (1997) Histone acetylation in chromatin structure and transcription. Nature (London) 389, 349-352